High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma

Yueh Min Lin, Wen Wei Sung, Ming Ju Hsieh, Shih Chen Tsai, Hung Wen Lai, Shu Mei Yang, Ko Hong Shen, Mu Kuan Chen, Huei Lee, Kun Tu Yeh, Chih Jung Chen

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

PD-L1 has been widely demonstrated to contribute to failed antitumor immunity. Blockade of PD-L1 with monoclonal antibody could modulate the tumor immune environment to augment immunotherapy. PD-L1 expression is also detected in several types of cancer and is associated with poor prognosis. However, the prognostic role of PD-L1 in oral squamous cell carcinoma (OSCC) is still controversial. Our aim was to determine the role of PD-L1 in the prognosis of OSCC patients to identify its potential therapeutic relevance. PD-L1 immunoreactivity was analyzed by immunohistochemistry in 305 cancer specimens from primary OSCC patients. The medium follow-up time after surgery was 3.8 years (range from 0.1 to 11.1 years). The prognostic value of PD-L1 on overall survival was determined by Kaplan-Meier analysis and Cox proportional hazard models. Higher PD-L1 expression is more likely in tumor tissues of female than male OSCC patients (P = 0.0062). Patients with distant metastasis also had high PD-L1 expression (P = 0.0103). Multivariate analysis identified high PD-L1 expression as an independent risk factor in males and smokers (males: hazard ratio = 1.556, P = 0.0077; smokers: hazard ratio = 2.058, P = 0.0004). We suggest that PDL1 expression, determined by IHC staining, could be an independent prognostic marker for OSCC patients who are male or who have a smoking habit.

Original languageEnglish
Article numbere0142656
JournalPLoS One
Volume10
Issue number11
DOIs
Publication statusPublished - Nov 1 2015

Fingerprint

squamous cell carcinoma
metastasis
prognosis
Squamous Cell Carcinoma
mouth
Neoplasm Metastasis
Hazards
neoplasms
Tumors
Neoplasms
smoking (habit)
immunotherapy
Kaplan-Meier Estimate
Proportional Hazards Models
Immunotherapy
Surgery
multivariate analysis
Habits
immunohistochemistry
Immunity

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Lin, Y. M., Sung, W. W., Hsieh, M. J., Tsai, S. C., Lai, H. W., Yang, S. M., ... Chen, C. J. (2015). High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma. PLoS One, 10(11), [e0142656]. https://doi.org/10.1371/journal.pone.0142656

High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma. / Lin, Yueh Min; Sung, Wen Wei; Hsieh, Ming Ju; Tsai, Shih Chen; Lai, Hung Wen; Yang, Shu Mei; Shen, Ko Hong; Chen, Mu Kuan; Lee, Huei; Yeh, Kun Tu; Chen, Chih Jung.

In: PLoS One, Vol. 10, No. 11, e0142656, 01.11.2015.

Research output: Contribution to journalArticle

Lin, YM, Sung, WW, Hsieh, MJ, Tsai, SC, Lai, HW, Yang, SM, Shen, KH, Chen, MK, Lee, H, Yeh, KT & Chen, CJ 2015, 'High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma', PLoS One, vol. 10, no. 11, e0142656. https://doi.org/10.1371/journal.pone.0142656
Lin, Yueh Min ; Sung, Wen Wei ; Hsieh, Ming Ju ; Tsai, Shih Chen ; Lai, Hung Wen ; Yang, Shu Mei ; Shen, Ko Hong ; Chen, Mu Kuan ; Lee, Huei ; Yeh, Kun Tu ; Chen, Chih Jung. / High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma. In: PLoS One. 2015 ; Vol. 10, No. 11.
@article{33c39fe4128441d6a36be11b7f60f5dd,
title = "High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma",
abstract = "PD-L1 has been widely demonstrated to contribute to failed antitumor immunity. Blockade of PD-L1 with monoclonal antibody could modulate the tumor immune environment to augment immunotherapy. PD-L1 expression is also detected in several types of cancer and is associated with poor prognosis. However, the prognostic role of PD-L1 in oral squamous cell carcinoma (OSCC) is still controversial. Our aim was to determine the role of PD-L1 in the prognosis of OSCC patients to identify its potential therapeutic relevance. PD-L1 immunoreactivity was analyzed by immunohistochemistry in 305 cancer specimens from primary OSCC patients. The medium follow-up time after surgery was 3.8 years (range from 0.1 to 11.1 years). The prognostic value of PD-L1 on overall survival was determined by Kaplan-Meier analysis and Cox proportional hazard models. Higher PD-L1 expression is more likely in tumor tissues of female than male OSCC patients (P = 0.0062). Patients with distant metastasis also had high PD-L1 expression (P = 0.0103). Multivariate analysis identified high PD-L1 expression as an independent risk factor in males and smokers (males: hazard ratio = 1.556, P = 0.0077; smokers: hazard ratio = 2.058, P = 0.0004). We suggest that PDL1 expression, determined by IHC staining, could be an independent prognostic marker for OSCC patients who are male or who have a smoking habit.",
author = "Lin, {Yueh Min} and Sung, {Wen Wei} and Hsieh, {Ming Ju} and Tsai, {Shih Chen} and Lai, {Hung Wen} and Yang, {Shu Mei} and Shen, {Ko Hong} and Chen, {Mu Kuan} and Huei Lee and Yeh, {Kun Tu} and Chen, {Chih Jung}",
year = "2015",
month = "11",
day = "1",
doi = "10.1371/journal.pone.0142656",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma

AU - Lin, Yueh Min

AU - Sung, Wen Wei

AU - Hsieh, Ming Ju

AU - Tsai, Shih Chen

AU - Lai, Hung Wen

AU - Yang, Shu Mei

AU - Shen, Ko Hong

AU - Chen, Mu Kuan

AU - Lee, Huei

AU - Yeh, Kun Tu

AU - Chen, Chih Jung

PY - 2015/11/1

Y1 - 2015/11/1

N2 - PD-L1 has been widely demonstrated to contribute to failed antitumor immunity. Blockade of PD-L1 with monoclonal antibody could modulate the tumor immune environment to augment immunotherapy. PD-L1 expression is also detected in several types of cancer and is associated with poor prognosis. However, the prognostic role of PD-L1 in oral squamous cell carcinoma (OSCC) is still controversial. Our aim was to determine the role of PD-L1 in the prognosis of OSCC patients to identify its potential therapeutic relevance. PD-L1 immunoreactivity was analyzed by immunohistochemistry in 305 cancer specimens from primary OSCC patients. The medium follow-up time after surgery was 3.8 years (range from 0.1 to 11.1 years). The prognostic value of PD-L1 on overall survival was determined by Kaplan-Meier analysis and Cox proportional hazard models. Higher PD-L1 expression is more likely in tumor tissues of female than male OSCC patients (P = 0.0062). Patients with distant metastasis also had high PD-L1 expression (P = 0.0103). Multivariate analysis identified high PD-L1 expression as an independent risk factor in males and smokers (males: hazard ratio = 1.556, P = 0.0077; smokers: hazard ratio = 2.058, P = 0.0004). We suggest that PDL1 expression, determined by IHC staining, could be an independent prognostic marker for OSCC patients who are male or who have a smoking habit.

AB - PD-L1 has been widely demonstrated to contribute to failed antitumor immunity. Blockade of PD-L1 with monoclonal antibody could modulate the tumor immune environment to augment immunotherapy. PD-L1 expression is also detected in several types of cancer and is associated with poor prognosis. However, the prognostic role of PD-L1 in oral squamous cell carcinoma (OSCC) is still controversial. Our aim was to determine the role of PD-L1 in the prognosis of OSCC patients to identify its potential therapeutic relevance. PD-L1 immunoreactivity was analyzed by immunohistochemistry in 305 cancer specimens from primary OSCC patients. The medium follow-up time after surgery was 3.8 years (range from 0.1 to 11.1 years). The prognostic value of PD-L1 on overall survival was determined by Kaplan-Meier analysis and Cox proportional hazard models. Higher PD-L1 expression is more likely in tumor tissues of female than male OSCC patients (P = 0.0062). Patients with distant metastasis also had high PD-L1 expression (P = 0.0103). Multivariate analysis identified high PD-L1 expression as an independent risk factor in males and smokers (males: hazard ratio = 1.556, P = 0.0077; smokers: hazard ratio = 2.058, P = 0.0004). We suggest that PDL1 expression, determined by IHC staining, could be an independent prognostic marker for OSCC patients who are male or who have a smoking habit.

UR - http://www.scopus.com/inward/record.url?scp=84955495338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955495338&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0142656

DO - 10.1371/journal.pone.0142656

M3 - Article

C2 - 26562534

AN - SCOPUS:84955495338

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 11

M1 - e0142656

ER -